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Background: Animal acariasis is one of the important veterinary skin diseases. Chemical drugs have been widely used
to treat and control this kind of disease. But many chemicals control could increase resistance in target species, toxicity
and environmental hazards. We found that the 9-oxo-10, 11-dehydroageraphorone (euptox A) extracted from E.
adenophorum has strong toxicity against P. cuniculi in vitro, but the in vivo acaricidal actions of euptox A have yet to be
investigated.
Results: A 14-day experiment was performed using rabbits that were naturally infested with P. cuniculi on a farm.
Rabbits were randomly divided into five groups; animals in groups A, B and C were treated in each ear topically with
4.0 ml of 2.0 and 1.0 g/L (w/v) euptox A, respectively. Animals in groups D and E were treated with ivermectin (by
injection; positive controls) and glycerol with water only (by embrocation; negative controls), respectively. Each rabbit
was treated twice with separate treatments on days 0 and 7. Rabbits were observed daily and detailed examinations
were performed on days 0, 7 and 14, to inspect the presence or absence of mites and scabs/crusts. Seven days after
the initial treatment, the mean clinical scores (presence of scabs/crusts) decreased from 3.48, 3.37, 3.43 and 3.45 to 0.37,
0.42, 0.78 and 0.38 in the ears of animals in groups A, B , C and D, respectively, which were similar to the observations
recorded in the positive control rabbits. However, the clinical score for negative control rabbits did not increase
significantly (P > 0.05) during the experiment, and this changed from 3.32 to 3.37 in the ears, and there were no
significant differences in clinical efficacy between left and right ears. After two treatments (0 and 7 d), the rabbits in
groups A, B, C and D had recovered completely 14 days after the last treatment and no recurrences of infection were
observed.
Conclusions: These results indicate that euptox A was potent compounds for the effective control of animal P. cuniculi
in vivo.
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Table 2 The clinical score of infection and degree of the
recovery from infection of the external ear margins in
rabbits (mean ± standard error)































Note: The different letters within a row denote significant differences between
the difference groups (P < 0.05). The numbers in brackets represent the clinical
therapeutic efficacy in accordance with the calculation of the decrease of the
mites. The different letters in brackets within a column denote significant
differences between the different treatment days (P < 0.05).
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Animal acariasis, an important veterinary diseases, may re-
duce the productivity and the quality of animal products,
even lead to death [1]. At present, chemical drugs are
widely used to treat and control the psoroptes and sarcoptic
mange in veterinary clinic, and obtained the relative good
treatment effectiveness, including ivermectin, and abamec-
tin, etc. But the chemical control could increase resistance
in target species, toxicity and environmental hazards [2].
A large number of reports have indicated that the sec-
ondary metabolites synthesized and accumulated in
Eupatorium adenophorum (E. adenophorum) have wide
biological activities. For example, there are reports of
chronic respiratory disease and exercise intolerance in
horses in Australia due to ingestion of E. adenophorum
[3]. The ethanol extract from leaves of E. adenophorum
were anti-Inflammatory potential [4], acaricidal activity
[5,6], antioxidant activity [7], and other extract form E.
adenophorum torium had toxic activity against Oncomela-
nia hupensis, the intermediate host snail of Schistosoma
japonicum [8], Tinea [9] and Aphis gossypii [10]. The acet-
one extract of E. adenophorum had strong toxicity against
Cabbage aphids and Brevicoryne brassicae [11].
9-oxo-10, 11-dehydroageraphorone (euptox A), is the
main toxin extracted from E. adenophorum [12,13].
Euptox A takes a large proportion of E. adenophorum
toxins [14,15], can cause not only the allergic bronchial
pneumonia of horses which is characterized by pulmonary
interstitial fibrosis, emphysema, alveolar epithelisation and
reduced tolerance to exercise [3,16], but the contact
dermatitis of other domestics animals like cattle and goats
[17]. Furthermore, according to some studies, for mice, le-
sions occur in the liver. The hepatic injury in these ani-
mals is characterised by multiple areas of focal necrosis of
the parenchyma associated with degeneration and loss of
the epithelium lining the small bile ducts [18,19]. Euptox
A belongs to a cadenine sesquiterpene. A large number
of reports indicated that the cadenine sesquiterpene has
wide biological activities such as antitumor activity [20],Table 1 Parameters used to evaluate the clinical score of
infection and degree of recovery
Infection and degree of recovery Clinical
score
Absence of scabs and/or mites 0
Irritation in ear canal but no mites observed 0.5
Small number of scabs in the ear canal, mites present 1
External ear canal filled with scabs, mites present 2
Scabs in ear canal and proximal 1/4 of pinna, mites present 3
1/2 pinna filled with scabs, mites present 4
3/4 of the pinna filled with scabs, mites present 5
All internal surface of the pinna full of scabs, mites present 6antigerminative activity [21], neurotrophic activity [22],
larvicidal activity [23], antiprotozoal activity [24], and
so on. Euptox A was found highly active against the fast
growing A549, Hela and Hep-2, and its activity was
concentration-dependent [25]. In a previous study,
euptox A exhibited strong toxicity against S. scabiei and
P. cuniculi in vitro [26], but the in vivo acaricidal ac-
tions of euptox A have yet to be investigated.
Thus, the aim of this present study was to assess the
clinical acaricidal efficacy of euptox A against P. cuniculi
in rabbits in vivo.Methods
Extraction and purification of euptox A
E. adenophorum was collected from Xichang City (102°
30222′E, 27°873213′S) of Sichuan Province, Southwest
China in July, 2012. Euptox A was extraction from E.
adenophorum by the Key laboratory of Animal Disease
and Human Health of Sichuan Agricultural University,
China [25-27].Experimental animals
Thirty rabbits that were naturally infected with P.cuniculi
were obtained from a farm affected by an outbreak. All
the animals were of similar age, weight and clinical score
(in terms of the presence/absence of scabs and crusts). In
all 30 rabbits, there were no significant difference between
the level of infection in the ears, and had not been treated
with acaricides and no other infectious diseases were
known to be present. Sampling procedures adhered to in-
stitutional ethical and animal care guidelines and all
methods were conducted in accordance with the Guide
for the Care and Use of Laboratory Animals adopted and
promulgated by the United National Institutes of health.
All experimental protocols were approved by review com-
mittee for the use of human or animal subjects of College
of veterinary medicine, Sichuan Agricultural University.
Figure 1 Clinical observations of rabbits treated with euptox A against P. cuniculi. (A)–(E) denote rabbits that were treated with euptox A
at 4, 2, 1 mg/ml, ivermectin and glycerol and water only, respectively. A1, B1, C1, D1 and E1 show the signs of infection before treatment; A2, B2,
C2, D1 and E1 show the observations at day 7; and A3, B3, C3, D1 and E1 show the observations at day 14.
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Table 3 The effects of euptox A on rabbit itching mite
negative transformation rate
Time 0 d 7 d 14 d Negative
transformation
rate %
Group A 24.33 ± 1.97 0.00 ± 0.00 0.00 ± 0.00 100.00
Group B 21.50 ± 2.17 0.00 ± 0.00 0.00 ± 0.00 100.00
Group C 18.61 ± 2.17 2.17 ± 1.72 0.00 ± 0.00 100.00
Group D 24.61 ± 2.07 0.00 ± 0.00 0.00 ± 0.00 100.00
Group E 19.83 ± 2.13 22.83 ± 2.48 24.00 ± 2.37 −21.03
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The euptox A was diluted from the concentration of 4
mg/ml to 1 mg/ml (4 mg/ml, 2 mg/ml and 1 mg/ml) in
10% glycerin.
The experimental procedures were performed as de-
scribed previously by [28]. The thirty rabbits were di-
vided into five equal groups at random (groups A, B, C,
D and E). Groups A, B and C were treated at days 0 and
7 with 4, 2 and 1 mg/ml of euptox A, respectively.
Groups D and E were treated twice with ivermectin (by
injection 200 μg/kg) and glycerol and water only (by
embrocation) as the positive and untreated control
groups, respectively. In the treatment process, each of
the left and right ears were treated with the use of a cot-
ton swab dipped with 2 ml of the euptox A, then embro-
cated treatment as an ointment. The presence of clinical
signs was assessed daily and any abnormal reactions were
recorded. Detailed examinations were performed on days
0, 7 and 14 which included an assessment of the presence
or absence of mites and an evaluation of clinical infection
and the degree of recovery. The criteria used to evaluate
the clinical infection score and degree of recovery can be
found in Table 1 [28].
Statistical analysis
Statistical analysis was performed using SPSS software
(SPSS, version 20.0) [29] to assess the presence of statis-
tically significant differences in infection and recovery
scores, and therapeutic effects of different concentra-
tions of euptox A and different treatment times. Signifi-
cance values were corrected for with Duncan’s multiple
comparisons test [30].
Results
The criteria used to evaluate the clinical infection score
and degree of recovery can be found in Table 1, The
mean degree of infection was similar in each group at
the start of the experiment and no significant differences
were detected (Table 2).
All infected rabbits treated with 4, 2 and 1 mg/ml of
euptox A (groups A, B and C) recovered and were com-
pletely cured by day 14 (Figure 1A3, B3 and C3). In
addition, the rabbits in group A-C with 4, 2 and 1 mg/ml
of euptox A displayed improved clinical signs during the
experiment, although redness and inflammation were
found in parts of the ear canals (Figure 1A2,B2 and C2).
However, after the second treatment, the infected rabbits
in group A-C were cured completely. Rabbits in group D
(positive control) exhibited improvements in clinical signs
during the experiment and no inflammation was observed
(Figure 1D2 and D3). However, rabbits treated with
negative control showed only minor signs of aggravated
(Figure 1E2 and E3). After determining that there was
no new crust formation after day 7, and that there wereno mites on otoscopic examination, we treated scabs
topically with the relevant euptox A (A, B and C
groups) or ivermectin (D group).
Mites were collected and burdens assessed to provide
values for mite reduction and negative transformation
rate (%). From day 7, no mites were present in the left
or right ears of any rabbits in these groups (A, B and D
group). In group C, there were small amount of mites.
Compared with the negative control group, treatment
with euptox A gave significant improvements in clinical
signs at each time point. The rabbit itching mite nega-
tive transformation rate in treatment group (A-D) were
up to 100% 14 d after treatment (Table 3), and there
were not badness (not irritant to the skin and toxicity).Discussion
Good clinical efficacy was achieved with the euptox A
extract from E. adenophorum, against the scab mites, P.
cuniculi. The clinical acaricidal efficacy of euptox A was
similar to that of injectable ivermectin, and this observa-
tion is consistent with the euptox A has strong toxicity
against S. scabiei and P. cuniculi in vitro [26], whilst con-
sistent with petroleum ether extract form E.adenophorum
against P. cuniculi in vitro [31]. The clinical acaricidal
efficacy was showed to be time- and concentration-
dependent, with the euptox A displaying similar effects
to the alcohol extract from E. adenophorum against
P. cuniculi. In the current study, the euptox A showed
better clinical acaricidal efficacy (2ml/ml) than the alco-
hol extract from E. adenophorum (1 g/ml) [32], whilst
the petroleum ether extract of neem oil comparatively
weak bioactivity (LC50, 500.0 ll/ml) [33].
E. adenophorum has been reported to have hepato-
toxic effects in rodents [15,34,35] which could limit its
development as an acaricidal agent. But the acute tox-
icity test and skin hypersensitive test of euptox A had
been finished, the euptox A were not irritant to the skin
and toxicity of rabbits. Combining our previous results
with this trial, we firmly believe that, euptox A shows a
good clinical therapeutic effect on animal acariasis.
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We believe that, after further in-depth study, euptox A, a
potent herbal drug, will be more widely applied in treat-
ments for humans and animals. This study provides a new
way for utilization of E. adenophorum and the euptox A has
the potential as acaricidal drugs in livestock, and future pos-
sible scope of the product in small animal vet medicine, e.g.
against Octodectes ear mites and other common ectopara-
sites of dogs and cats. But in order to make the research sys-
tematic, the mechanism of action has yet to be determined.
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